CNBX Pharmaceuticals Inc. (CNBX) Short term Debt (2015 - 2026)

CNBX Pharmaceuticals' (CNBX) quarterly Short term Debt came in at $120000.0 in Q2 2026, up 60.0% on a QoQ basis from $75000.0 in Q1 2026.

CNBX Pharmaceuticals Inc. (CNBX) Short term Debt (2015 - 2026) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 7 years of Short term Debt data on file, last reported at $120000.0 in Q2 2026.

Quarterly Short term Debt changed N/A year-over-year to $120000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $120000.0 (changed N/A YoY) and the FY2024 annual result came in at $1.3 million, down 3.61% from the prior year.
Short term Debt advanced to $120000.0 in Q2 2026, from $75000.0 in the prior quarter.
In the past five years, Short term Debt ranged from a high of $1.8 million in Q4 2022 to a low of $75000.0 in Q1 2026.
A 4-year average of $1.2 million and a median of $1.3 million in 2023 frame the typical range for Short term Debt.
Annual changes were most pronounced in 2022 — Short term Debt surged 101.71% — and 2023, when it fell 23.6%.
Tracing CNBX's Short term Debt over 4 years: stood at $1.8 million in 2022, then dropped by 23.8% to $1.3 million in 2023, then declined by 3.61% to $1.3 million in 2024, then sank by 90.73% to $120000.0 in 2026.
The last three Short term Debt figures came in at $120000.0 (Q2 2026), $75000.0 (Q1 2026), and $1.3 million (Q3 2024), per Business Quant data.

Download Data